Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-06

Clinical Trial Update: Evaluation of the Efficacy of MACitentan in the Treatment of CoronaryMICrovascular Angina (MACMIC) [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial is recruiting to evaluate the efficacy of macitentan for treating coronary microvascular angina. The study is sponsored by China-Japan Fr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Macitentan (macitentan)

Snippet

Sponsor: China-Japan Friendship Hospital | Conditions: Coronary Microvascular Angina, Macitentan | EARLY_Phase 1 | Status: RECRUITING